| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2793 | |||||||||||||||||||||||
| Submitter : | Mrs. Donna Ploof | Date & Time: | 12/08/2006 09:12:38 | |||||||||||||||||||||
| Organization : | Mrs. Donna Ploof | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I strongly disagree with the use of aborted fetal cells in the manufacturing of vaccinations. | ||||||||||||||||||||||||